QA: Onconetix Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001782107_2026_Onconetix_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001782107, Onconetix Inc

  xvar xval
0 AssetsCurrent 6,066,774
1 IntangibleAssetsNetIncludingGoodwill 18,549,005
2 PropertyPlantAndEquipmentNet 37,085
3 remainder_Assets 273,774
4 LiabilitiesCurrent 9,135,925
5 LiabilitiesNoncurrent 24,362
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 206,753
8 SellingGeneralAndAdministrativeExpense 4,720,887
9 ResearchAndDevelopmentExpense 24,900
10 remainder_Expenses 21,074,108
11 remainder_Revenues 1,627,825
12 remainder_NetIncome -3,224,019
13 remainder_ComprehensiveNetIncome -5,096,401
  yvar yval
0 Assets 24,926,638
1 Liabilities 9,160,287
2 Expenses 26,026,648
3 Revenues 1,627,825
4 StockholdersEquity 15,766,351
5 NetIncome -27,622,842
6 ComprehensiveNetIncome -30,171,042
7 BaseVar 35,030,909
8 EconomicCapitalRatiobeforeLimitedLiability 0.246
9 EconomicCapitalRatio 1.65

Edgar->Model Mapping

Feature Distribution

Change over Time